Allergen immunotherapy (AIT) is a therapeutic vaccination approach to IgE‐mediated type I hypersensitivity diseases by inducing immunologic tolerance to allergens, which includes subcutaneous immunotherapy (SCIT), sublingual immunotherapy (SLIT) and other alternative routes.135. This evidence concerns the gene IGHE and allergic disease.